|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
153 |
$53,680.05 |
2.76% |
| LivaNova Plc |
LIVN |
G5509L101 |
627 |
$52,310.61 |
2.69% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,264 |
$51,228.68 |
2.63% |
| Baxter International Inc. |
BAX |
071813109 |
2,294 |
$50,559.76 |
2.60% |
| Revvity, Inc. |
RVTY |
714046109 |
438 |
$49,502.76 |
2.55% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
368 |
$48,343.90 |
2.49% |
| Agilent Technologies, Inc. |
A |
00846U101 |
342 |
$46,515.42 |
2.39% |
| Waters Corporation |
WAT |
941848103 |
123 |
$46,052.43 |
2.37% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
505 |
$45,843.90 |
2.36% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,385 |
$44,221.58 |
2.27% |
| DexCom, Inc. |
DXCM |
252131107 |
614 |
$43,065.96 |
2.22% |
| Teleflex Incorporated |
TFX |
879369106 |
332 |
$43,113.52 |
2.22% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
141 |
$42,411.39 |
2.18% |
| Olympus Corporation |
7733.JP |
J61240107 |
4,040 |
$42,057.08 |
2.16% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
576 |
$41,316.48 |
2.13% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,534 |
$41,033.47 |
2.11% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
170 |
$40,822.67 |
2.10% |
| Danaher Corporation |
DHR |
235851102 |
207 |
$40,611.33 |
2.09% |
| Align Technology, Inc. |
ALGN |
016255101 |
227 |
$40,503.61 |
2.08% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,960 |
$40,475.51 |
2.08% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
79 |
$40,529.37 |
2.08% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,293 |
$40,201.90 |
2.07% |
| Becton, Dickinson and Company |
BDX |
075887109 |
255 |
$39,759.60 |
2.05% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
197 |
$39,308.46 |
2.02% |
| The Cooper Companies, Inc. |
COO |
216648501 |
552 |
$39,203.04 |
2.02% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
422 |
$39,288.20 |
2.02% |
| Stryker Corporation |
SYK |
863667101 |
116 |
$38,594.36 |
1.99% |
| Steris Plc |
STE |
G8473T100 |
177 |
$38,173.59 |
1.96% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,744 |
$37,830.02 |
1.95% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
30 |
$37,912.50 |
1.95% |
| Penumbra, Inc. |
PEN |
70975L107 |
119 |
$37,678.97 |
1.94% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
435 |
$37,518.75 |
1.93% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,382 |
$37,601.89 |
1.93% |
| Abbott Laboratories |
ABT |
002824100 |
392 |
$36,895.04 |
1.90% |
| Medtronic Plc |
MDT |
G5960L103 |
451 |
$36,521.98 |
1.88% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
538 |
$35,378.88 |
1.82% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
87 |
$35,208.90 |
1.81% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,344 |
$35,223.60 |
1.81% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
888 |
$34,608.16 |
1.78% |
| Alcon Inc. |
ALC.SW |
H01301128 |
504 |
$34,365.76 |
1.77% |
| ResMed Inc. |
RMD |
761152107 |
172 |
$34,449.88 |
1.77% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
585 |
$34,040.04 |
1.75% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
343 |
$32,811.38 |
1.69% |
| Insulet Corporation |
PODD |
45784P101 |
200 |
$31,650.00 |
1.63% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$30,671.34 |
1.58% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
11,000 |
$30,579.52 |
1.57% |
| BioMerieux |
BIM.FP |
F1149Y232 |
372 |
$30,186.55 |
1.55% |
| Boston Scientific Corporation |
BSX |
101137107 |
637 |
$28,174.51 |
1.45% |
| Cochlear Limited |
COH.AU |
Q25953102 |
323 |
$26,303.44 |
1.35% |
| US Dollar |
$USD |
|
8,832 |
$8,832.25 |
0.45% |
| Japanese Yen |
$JPY |
|
101,746 |
$629.03 |
0.03% |
| New Zealand Dollar |
$NZD |
|
679 |
$382.99 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|